share_log

Biora Therapeutics | DEFA14A: Others

Biora Therapeutics | DEFA14A: Others

Biora Therapeutics | DEFA14A:其他
美股sec公告 ·  04/24 16:09
Moomoo AI 已提取核心信息
Biora Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 5, 2024. Stockholders of record as of April 16, 2024, are invited to attend the meeting online, with registration required by June 4. The agenda includes the election of six director nominees to serve until the 2025 Annual Meeting, the ratification of KPMG LLP as the independent auditor for the year ending December 31, 2024, an amendment to increase the number of authorized shares of common stock, and the authorization of share issuance underlying certain warrants in compliance with Nasdaq Listing Rule 5635(d). The Board of Directors recommends a vote in favor of all proposals. Proxy materials are available online, and stockholders may request paper copies until May 24, 2024.
Biora Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 5, 2024. Stockholders of record as of April 16, 2024, are invited to attend the meeting online, with registration required by June 4. The agenda includes the election of six director nominees to serve until the 2025 Annual Meeting, the ratification of KPMG LLP as the independent auditor for the year ending December 31, 2024, an amendment to increase the number of authorized shares of common stock, and the authorization of share issuance underlying certain warrants in compliance with Nasdaq Listing Rule 5635(d). The Board of Directors recommends a vote in favor of all proposals. Proxy materials are available online, and stockholders may request paper copies until May 24, 2024.
Biora Therapeutics, Inc.已宣布其年度股东大会将于2024年6月5日虚拟举行。邀请截至2024年4月16日的登记股东在线参加会议,并需要在6月4日之前注册。该议程包括选举六名董事候选人,任期至2025年年会,批准毕马威会计师事务所为截至2024年12月31日的年度的独立审计师,修正增加普通股的授权数量,以及批准根据纳斯达克上市规则5635(d)发行某些认股权证的股票。董事会建议对所有提案投赞成票。代理材料可在线获取,股东可以在2024年5月24日之前索取纸质副本。
Biora Therapeutics, Inc.已宣布其年度股东大会将于2024年6月5日虚拟举行。邀请截至2024年4月16日的登记股东在线参加会议,并需要在6月4日之前注册。该议程包括选举六名董事候选人,任期至2025年年会,批准毕马威会计师事务所为截至2024年12月31日的年度的独立审计师,修正增加普通股的授权数量,以及批准根据纳斯达克上市规则5635(d)发行某些认股权证的股票。董事会建议对所有提案投赞成票。代理材料可在线获取,股东可以在2024年5月24日之前索取纸质副本。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息